德尔菲共识研究:确定改善重症监护患者转至医院病房过程中用药安全的优先事项
该研究采用三轮电子德尔菲调查,纳入重症监护、医院病房医护人员和公众代表三个专家组共129名参与者,旨在确定改善重症监护患者转至医院病房过程中用药安全的干预措施和结局测量优先事项。129名参与者中84.5%完成全部三轮,最终就48项干预措施、13项药物结局测量和11项患者结局测量达成共识。第一轮收集158条评论,包含超过200项实施障碍和促进因素,并按患者安全系统工程倡议3.0模型进行社会技术分类。常见促进因素包括明确规定的角色和责任、患者和家属作为行动主体、药物相关信息易于获取以及清晰的用药计划和沟通。研究结果为未来患者用药安全干预研究的设计提供了依据。
要点
- 129名参与者(84.5%)完成三轮德尔菲调查,三个专家组(重症监护、医院病房医护人员、公众代表)就48项干预措施达成共识。
- 共识还涵盖13项药物结局测量和11项患者结局测量,将用于指导未来患者用药安全干预研究的设计。
- 第一轮收集158条评论,包含超过200项实施障碍和促进因素,按患者安全系统工程倡议3.0模型分类。
- 常见促进因素包括明确规定的角色和责任(10.7%,组织条件)、患者和家属作为行动主体(8.8%,照护团队)、药物相关信息易于获取(7.8%,工具和技术)、清晰的用药计划和沟通(7.3%,任务)。
适用人群与场景
- 重症监护后存活并转至低 acuity 医院病房的患者。
- 三个专家组:重症监护专业人员、医院病房医护人员和公众代表。
诊断标准与关键阈值
- 德尔菲共识标准:项目按重要性分级,采用预设的重要标准;需在所有三个专家组中达成共识。
研究设计与关键结果
- 研究类型:三轮电子德尔菲调查,三个专家组共129名参与者,覆盖重症监护、医院病房医护人员和公众代表。
- 109名(84.5%)参与者完成全部三轮德尔菲调查。
- 共识达成:48项干预措施、13项药物结局测量和11项患者结局测量。
- 第一轮提供158条评论,包含超过200项个体实施障碍和促进因素。
- 常见促进因素:明确规定的角色和责任(10.7%,组织条件)、患者和家属作为行动主体(8.8%,照护团队)、药物相关信息易于获取(8.7%,工具和技术)、清晰的用药计划和沟通(7.3%,任务)。
证据类型、等级与局限
- 证据类型:德尔菲共识研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 研究识别了改善重症监护患者转至医院病房用药安全的干预措施优先事项,以及需要测量的重要药物和患者结局,将用于指导未来患者用药安全干预研究的设计。
- 实施干预时需考虑已识别的障碍和促进因素,常见促进因素包括明确规定的角色和责任、患者和家属作为行动主体、药物相关信息易于获取以及清晰的用药计划和沟通。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Intensive care patients surviving to transfer to a lower-acuity hospital ward experience ongoing challenges to their recovery and lack a well-defined and developed care pathway. The transfer process to a hospital ward exposes intensive care patients to high rates of medication errors, which increase their risk of adverse drug events.
OBJECTIVE: The aims of this study were to identify priorities for medication-related intervention components and outcome measures for improving medication safety for intensive care patients transferring to a hospital ward.
METHODS: Three panels involving 129 participants covering (i) intensive care, (ii) hospital ward health-care professionals and (iii) public representatives completed an electronic Delphi survey conducted over three phases. The Delphi process comprised three sections (medication-related intervention components, medication outcomes and patient outcomes). Items were graded in their level of importance, with predefined important criteria. Item agreement required consensus across all three panels. Intervention barriers and facilitators identified in participant comments were categorized according to a socio-technical systems approach to the patient journey and patient safety (Systems Engineering Initiative for Patient Safety 3.0 model).
RESULTS: Of the 129 (84.5%) participants, 109 completed all three Delphi phases. Consensus was achieved for 48 intervention components, 13 medication outcome measures and 11 patient outcome measures. Phase 1 provided 158 comments comprising >200 individual barriers and facilitators to intervention delivery. Frequently cited facilitators included clearly specified roles and responsibilities (10.7% (organizational conditions)), patient and family as agents (8.8% (care team)), medicines-related information easily accessible (7.8% (tools and technologies)) and clear medication plan and communication (7.3% (tasks)).
CONCLUSIONS: Our findings provide identification of priorities for medication-related intervention components to improve medication safety for intensive care patients transferring to a hospital ward. Prioritization is complemented by the identification and socio-technical categorization of barriers and facilitators to intervention delivery. The identified important medication and patient outcomes to measure will inform the design of a future patient medication safety intervention study.
参考来源
- Bourne RS, Jennings JK, Ashcroft DM, et al. A Delphi consensus study to identify priorities for improving and measuring medication safety for intensive care patients on transfer to a hospital ward. Int J Qual Health Care. 2022. PMID: 36208155. doi:10.1093/intqhc/mzac082
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。